leukaemia symposium Flashcards
1
Q
what is cancer?
A
- transformed cell phenotype: uncontrolled proliferation, failure to undergo apoptosis
- genetic: oncogenes, tumour suppressor genes
- epigenetic: dysregulated gene expression, aberrant DAN methylation
2
Q
what are the clinical features of cancer?
A
- myelofibrosis (causes splenomegaly)
- polycythemia rubra vera (too many red cells)
- essential thrombocythemia (too many platelets)
3
Q
what is JAK-STAT signalling?
A
signal transduction pathways for EPO and G-CSF
4
Q
what is acute myeloid leukaemia?
A
- uncontrolled proliferation of primitive cells in the bone marrow
- causes bone marrow failure: anaemia, infections, bleeding
- blasts identified on blood film
5
Q
what are the clinical features of myeloid leukaemia?
A
- anaemia
- infections
- DIC
- ulcers
- infiltration
- bruising
6
Q
how is acute myeloid leukaemia treated?
A
- chemotherapy kills rapidly dividing cells: combination regimes, myelo-ablative cycles of treatment
- supportive therapy: antibiotics, antifungals, transfusions of blood and platelets
- allogenic stem cell transplantations: allograft (full or reduced intensity)
7
Q
what are the supportive measures for acute myeloid leukaemia?
A
- transfusions: red cells, platelets, cryo/FFP
- antibiotics: prophylactic, broad spectrum
- antifungals
8
Q
what are the risk of neutropenic sepsis?
A
- medical emergency
- gram -ve bacteria are most dangerous
- blood cultures and blind antibiotic therapy if fever >38 degrees
- 1st line - Tazocin +/- gentamicin
- 2nd line - wtich to meropenem +/- teicoplanin (for gram +ve)
- 3rd line - add antifungal
- resuscitate patient with iv fluids if hypotensive
- may require inotropic support on ICU
9
Q
what is graft vs host disease?
A
- caused by donor/host mismatches in major and minor HLA loci
- results in acute GVH and chronic GVH post transplant
- prevented by using: T cell depletion of infused donor cells or immunosuppression of recipient
- effect how the stem cell transplant cures leukaemia
- donor lymphocyte infusions post Tx can treat relapse by augmenting GVL effect
10
Q
what are the clinical manifestations of graft vs host disease?
A
- skin rash
- diarrhoea
- deranged liver function